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Abstract 
Introduction: Herpes simplex virus encephalitis (HSE) is an acute infection accompanied 
by significant morbidity and mortality with the diagnosis often made by cerebrospinal 
fluid (CSF) polymerase chain reaction (PCR) testing.  
Case Presentation: We report a case of a healthy 35-year-old woman presenting with 
altered mental status. Due to suspicion of herpes encephalitis, a CSF PCR for herpes virus 
was sent for examination and acyclovir was started. The patient had an immediate 
response to acyclovir; however, when the PCR returned negative she was discharged 
without therapy. The altered mental status returned and she was started on acyclovir 
therapy and a second CSF PCR sample was sent and was again negative. MRI performed 
at initial hospitalization was negative, but a repeat MRI demonstrated bilateral temporal 
lobe involvement suggestive of herpes encephalitis. The patient was successfully treated 
for 21 days with acyclovir.  
Conclusion: CSF PCR for herpes virus is highly sensitive and specific and remains the 
standard for diagnosing herpes encephalitis. Clinicians should be aware of the pitfalls of 
CSF PCR testing, specifically false-negative results. Although rare, these false negatives 
can result in premature termination of treatment. 
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Introduction 
Herpes simplex virus encephalitis (HSE) is an acute infection accompanied by 
significant morbidity and mortality [1]. Clinically, HSE has a prodrome of fever, 
headache, seizure, focal neurologic signs, and altered consciousness [2]; however, mild or 
atypical presentations have been reported [3–9]. The diagnosis of HSE is generally clinical 
with confirmatory tests including lumbar puncture and cerebrospinal fluid (CSF) 
polymerase chain reaction (PCR) testing. Auxiliary tests to aid diagnosis include 
electroencephalogram (EEG), computed tomography (CT), and especially magnetic 
resonance imaging (MRI). We present a patient initially suspected to have HSE although 
with a negative MRI and CSF examination including PCR for herpes simplex virus 
(HSV). The patient was started on acyclovir with an initial response but was discharged 
after the PCR was negative. The patient returned with worsening symptoms, this time 
with MRI and EEG both suggestive of HSE; however, repeat CSF PCR for HSV was again 
negative. The high sensitivity and specificity of PCR for HSV leads physicians to rely on 
this test for making or excluding the diagnosis of HSE, although false-negative results 
may occur. Cases with a high pre-test probability for HSE and suggestive MRI and/or 
EEG examinations, although with two false-negative PCR tests, are seldom encountered 
or reported in the literature. 
Case Report 
A 35-year-old Hispanic female without a significant past medical history arrived at the emergency 
department complaining of headache, dizziness, nausea, and vomiting for 2 days prior to admission. 
The dizziness and nausea were connected with food intake. The headache was localized to the frontal 
region and accompanied by photophobia and phonophobia and six episodes of vomitus. Immediately 
prior to admission, the patient had had a witnessed generalized seizure of 30–45 s duration without 
bowel or bladder incontinence and developed postictal confusion without postictal lateralized 
neurological deficits. At the time of admission, she was disoriented to person, place, and time with a 
GCS of 9. Initially, she was afebrile and physical examination was without focal findings. Laboratory 
examination was unremarkable. Lumbar puncture revealed clear fluid with glucose 69 mg/dl, protein 31 
mg/dl, 2 WBC, 3 RBC, no monocytes or lymphocytes, and without xanthochromia. CSF bacterial and 
cryptococcal antigen testing was negative. Urine analysis, toxicology, culture of blood, CSF, and urine 
were all negative. CSF was sent for HSV-PCR testing. CT scan was without acute pathology. Acyclovir 
(10 mg/kg i.v., 3 times per day) was started as empiric treatment in addition to levetiracetam for seizure 
prevention. EEG showed generalized slowing suggestive of encephalopathy although it was extremely 
limited due to patient movement and inability to cooperate. MRI was without acute pathology. Twenty-
four hours after initiation of acyclovir the patient was lethargic but not confused. Forty-eight hours 
following admission, the patient’s mental status was reported to be at baseline, GCS 15, and she was 
eager to return home. Acyclovir was switched to oral preparation and after one dose, the CSF HSV-PCR 
returned negative, and the patient was discharged without further need to continue antiviral 
medication. Within 24 h, she returned to the emergency department complaining of severe headaches, 
vomiting, and an episode of unresponsiveness, slurred speech, and blank starring as reported by family 
members. At the time of admission, she had intermittent episodes of confusion; however, the remainder 
of the physical examination was normal. Laboratory examination was again unremarkable. Acyclovir 
(10 mg/kg i.v., 3 times per day) was restarted. Repeat lumbar puncture was performed with glucose 79 
mg/dl, protein 24 mg/dl, 50 WBC, 17 RBC, and negative for xanthochromia, cryptococcal antigen, 
VDRL, RPR, bacterial antigens, Lyme, West Nile antigen, and CMV antigen. Serum HIV test was 
nonreactive. CSF HSV-PCR was sent for repeat analysis. After careful consideration of the differential 
diagnosis of our patient, attempts were made to exclude limbic encephalitis with NMDA receptor 
antibody test, which was ultimately negative. Overnight, the patient became increasingly confused, 
delirious, and extremely agitated followed by a witnessed tonic-clonic seizure. Respiratory distress 
ensued, and due to the inability to protect her airway, intubation and mechanical ventilation was 
initiated and a loading dose of valproic acid was started for seizure control. She became febrile to a Case Rep Neurol 2011;3:172–178 
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maximum of 101.3°F (38.5°C) and developed thick endobronchial secretions identified as Gram-
positive cocci and Gram-negative rods. She remained febrile with a chest X-ray finding suggestive of 
developing infiltrate at the right lung base. Repeat EEG demonstrated absence of normal background 
activity with generalized slowing and presence of periodic lateralized epileptiform discharges. Repeat 
MRI had increased signal intensity in the medial aspect of the temporal lobes, more marked on the left 
than on the right, and was felt to be compatible with an acute phase of herpes encephalitis (fig. 1, fig. 2, 
fig. 3). The second CSF HSV-PCR returned negative. The patient remained encephalopathic for 1 week 
with minimal improvement during which time her pneumonia resolved. She improved slowly with 
acyclovir treatment with confusion waning each day. She was transferred to acute rehabilitation where 
she completed a 21-day course of acyclovir. Three weeks after the second admission, the patient had 
returned to baseline and was able to leave the medical center. 
Written informed consent was obtained from the patient for use of medical information and images 
for publication of this case report. A copy of the written informed consent is available for review by the 
Editor-in-Chief of this journal. 
Discussion 
With the discovery of PCR, diagnosis of central nervous system infections has become 
more sensitive and specific, particularly with infections caused by the herpes virus. PCR is 
considered the standard for the diagnosis of HSE, although specific CSF serologic testing 
can be employed in cases where suspicion remains high in the setting of a negative PCR 
test. Retrospective diagnosis can be made with the presence of anti-HSV IgG in the CSF 
[10]. PCR allows for the detection of minute quantities of viral DNA or RNA present in 
fluids and tissues by nucleic acid amplification over a short time period [11] and has 
nearly replaced brain biopsy for diagnosis of HSE in regions where the test can be 
performed. Negative PCR tests are associated with low CSF protein and leukocyte counts 
[10], and in such cases, clinical suspicion should dictate the treatment course. The 
sensitivity and specificity of CSF PCR for HSV exceeds 95%, allowing exclusion of HSE in 
patients with high pre-test probability should the result return negative [12]. In the study 
by Lakeman and Whitley [12], PCR sensitivity and specificity were reported as 98 and 
94%, respectively, with positive and negative predictive values of 95 and 98%, respectively, 
when compared with brain biopsy. However, in patients with high clinical probability of 
HSE, a negative PCR result, while decreasing the likelihood of HSE, does not entirely 
exclude the possibility of infection. Negative PCR results generally allow for the 
discontinuations of acyclovir treatment. Few reports exist identifying HSE in patients 
with negative PCR [13–15]. Puchhammer-Stockl et al. [14] reported 3 patients with MRI 
and clinical evidence of HSE with negative PCR tests. Denes et al. [13] reported a series of 
3 cases of HSE confirmed by CSF antibody testing in the setting of negative PCR tests. 
Possible explanations for negative PCR results have been suggested and include: PCR sent 
very early in the disease development (days 1–4 with neurological symptoms) and viral 
load too low for detection, although this is unlikely as the PCR technique by virtue of the 
amplification process allows for the detection of minute amounts of viral copies, as low as 
10 copies of viral inhibitors, and a small-volume CSF sample [11, 14, 16]. In addition, low 
CSF cell counts, variation in primers used during PCR processing, sample dilution, and 
location of infection in the central nervous system have all been suggested as the cause for 
false-negatives results [1, 14, 17]. Denes et al. [13] recommend repeating the PCR 4 days 
after development of symptoms and before deciding the patient does not have HSE and 
prematurely concluding acyclovir treatment. Patients with normal diagnostic tests and 
mild clinical symptoms are more likely to have negative PCR tests [18]. In our case, the 
patient had a repeat PCR sent 6 days after the development of symptoms, and despite Case Rep Neurol 2011;3:172–178 
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suggestive MRI and EEG and worsening clinical symptoms, the result was negative. 
Attempts were made to uncover an alternative diagnosis according to the experiences 
highlighted by Chataway et al. [19]. 
Radiographically, the most common areas of involvement are the medial temporal 
lobes, which are best observed with MRI [20]. Sensitivity of MRI is reported to be best 48 
h after onset of symptoms and approaches 85% [20], although it can be falsely negative in 
very early stages on infection. EEG may serve as an occasional adjunct in the diagnosis of 
HSE, demonstrating periodic lateralized epileptiform discharges as characteristic findings 
[20]. Specificity of EEG remains low in the diagnosis of HSE when used as a single 
diagnostic exam but can be helpful when PCR is negative in patients with high clinical 
probability [20]. In our case, the MRI on initial presentation failed to demonstrate any 
significant areas of disease, although repeat MRI, 6 days following onset of symptoms, 
revealed florid changes suggestive of HSV infection. 
Acyclovir is the only treatment shown to significantly improve prognosis [21]. The 
morbidity and mortality increases dramatically as the time to treatment increases [22]. 
Treatment course is weight based in adults, roughly 10 mg/kg every 8 h intravenously for 
10–21 days. Repeat MRI after successful treatment with acyclovir is generally unnecessary 
[23]. 
Conclusion 
Suspicion of HSE should remain high in all cases of acute encephalitis, especially in the 
absence of alternative diagnoses, even in cases when PCR examination is negative. In such 
cases, repeating lumbar puncture should be entertained with repeat HSV-PCR testing and 
possible serologic testing of the CSF. In our case, the patient had clinical symptoms, MRI 
and EEG suggestive of HSE, although with two negative PCR tests separated in time. In 
patients with high clinical suspicion and negative HSV-PCR, repeat lumbar puncture 
should be considered and empirical acyclovir treatment should be considered. In our 
case, continuation of acyclovir was warranted and proved efficacious as the patient 
achieved near-complete resolution. In all such cases, treatment with acyclovir should 
ensue until the diagnosis of HSE can be confidently excluded. 
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Fig. 1. MRI axial FLAIR with increased signal intensity at the medial temporal lobe (arrow). 
 
 
 
Fig. 2. MRI axial T2-weighted image identifying increased signal intensity at the left temporal lobe 
(arrows). 
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Fig. 3. MRI axial T2-weighted image identifying increased signal intensity at the left temporal lobe 
(arrow). Image contrast brightened. 
 
References 
1  Domingues RB, Lakeman FD, Mayo MS, Whitley RJ: Application of competitive PCR to cerebrospinal fluid 
samples from patients with herpes simplex encephalitis. J Clin Microbiol 1998;36:2229–2234. 
2  Whitley RJ, Soong SJ, Linneman C Jr, et al: Herpes simplex encephalitis: clinical assessment. JAMA 
1982;247:317–320. 
3  Fodor PA, Levin MJ, Weinberg A, Sandberg E, Sylman J, Tyler KL: Atypical herpes simplex virus encephalitis 
diagnosed by PCR amplification of viral DNA from CSF. Neurology 1998;51:554–559. 
4  Klapper PE, Cleator GM, Longson M: Mild forms of herpes encephalitis. J Neurol Neurosurg Psychiatry 
1984;47:1247–1250. 
5  Shelley BP, Raniga SB, Al-Khabouri J: An unusual late complication of intracerebral haematoma in herpes 
encephalitis after successful acyclovir treatment. J Neurol Sci 2007;252:177–180. 
6  Ohta K, Tabata M, Nakachi I, et al: HSV encephalitis with posterior localization. Neurology 2003;61:862. 
7  Ohta K, Funaki M, Tanaka M, Suzuki N: Early cerebellar involvement on diffusion-weighted magnetic 
resonance images in herpes simplex encephalitis. J Neurol 1999;246:736–738. 
8  Gkrania-Klotsas E, Lever AML: Herpes simplex I encephalitis presenting as a brain haemorrhage with normal 
cerebrospinal fluid analysis: a case report. J Med Case Rep 2008;2:387. 
9  Harrison NA, MacDonald BK, Scott G, Kapoor R: Atypical herpes type 2 encephalitis associated with normal 
MRI imaging. J Neurol Neurosurg Psychiatry 2003;74:974–976. 
10  Tiege XD, Rozenberg F, Burlot K, Gaudelus J, Ponsot G, Heron B: Herpes simplex encephalitis: diagnostic 
problems and late relapse. Dev Med Child Neurol 2006;48:60–63. 
11  DeBiasi RL, Kleinschmidt-DeMasters BK, Weinberg A, Tyler KL: Use of PCR for the diagnosis of herpesvirus 
infections of the central nervous system. J Clin Virol 2002;25:S5–S11. 
12  Lakeman FD, Whitley RJ: Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to 
cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and 
Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1995;171:857–863. Case Rep Neurol 2011;3:172–178 
DOI: 10.1159/000330298 
Published online: 
August 4, 2011 
© 2011 S. Karger AG, Basel
ISSN 1662–680X 
www.karger.com/crn   
 
 
 
178
13  Denes E, Labach C, Durox H, Adoukonou T, Weinbreck P, Magy L, Ranger-Rogez S: Intrathecal synthesis of 
specific antibodies as a marker of herpes simplex encephalitis in patients with negative PCR. Swiss Med Wkly 
2010;140:E1–E4. 
14  Puchhammer-Stockl E, Presterl E, Croy C, Aberle S, Popow-Kraupp T, Kundi M, Hofmann H, Wenninger U, 
Godl I: Screening for possible failure of herpes simplex virus PCR in cerebrospinal fluid for the diagnosis of 
herpes simplex encephalitis. J Med Virol 2001;64:531–536. 
15  Aurelius E, Johansson B, Skoldenberg B, Forsgren M: Encephalitis in immunocompetent patients due to herpes 
simplex virus type 1 or 2 as determined by type specific polymerase chain reaction and antibody assays of 
cerebrospinal fluid. J Med Virol 1993;39:179–186. 
16  Selvaraju SB, Wurst M, Horvat RT R.S.: Performance of three different HSV ID/typing assays for detection and 
typing of herpes simplex virus in cerebrospinal fluid. Diagn Microbiol Infect Dis 2009;63:286–291. 
17  Puchhammer-Stockl E, Heinz FX, Kundi M, Popow-Kraupp T, Grimm G, Millner MM, Kunz C: Evaluation of 
the polymerase chain reaction for diagnosis of herpes simplex virus encephalitis. J Clin Microbiol 1993;31:146–
148. 
18  Domingues RB, Tsanclis AM, Pannuti CS, Mayo MS, Lakeman FD: Evaluation of the range of clinical 
presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid 
samples. Clin Infect Dis 1997;25:86–91. 
19  Chataway J, Davies NWS, Farmer S, Howard RS, Thompson EJ, Ward KN: Herpes simplex encephalitis: an 
audit of the use of laboratory diagnostic tests. QJM 2004;97:325–330. 
20  Al-Shekhlee A, Kocharian N, Suarez JJ: Re-evaluating the diagnostic methods in herpes simplex encephalitis. 
Herpes 2006;13:17–19. 
21  Raschilas F, Wolff M, Delatour F, Chaffaut C, De Broucker T, Chevret S, Lebon P, Canton P, Rozenberg F: 
Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter 
study. Clin Infect Dis 2002;35:254–260. 
22  Lakeman FD, Whitley RJ: Herpes simplex virus infection of the central nervous system: therapeutic and 
diagnostic considerations. Clin Infect Dis 1995;20:414–420. 
23  Lee JW, Kim I, Kim WS, Yeon KM, Lee H, Hwang YS: Herpes simplex encephalitis: MRI findings in two cases 
confirmed by polymerase chain reaction assay. Pediatr Radiol 2001;31:619–623. 